A Clinical Efficacy Prediction Study of Acupuncture treatment for Migraine Based on Neuroimage and COMT Gene Polymorphism

Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged from 18 to 65 years;
•2. Migraine without aura patients: meetting the ICHD-3 2018 edition diagnostic criteria for migraine (without aura) published by the International Headache Society;
•3. With a history of migraine for over 6 months;
•4. Migraine attacks more than once a month in the past 3 months;
•5. Did not receive no acupuncture treatment in the past 3 months;
•6. Did not take any preventive, long-acting analgesics, psychotropic drugs (such as Prozac and estazolam eurodin) or vasoactive drugs for migraine in the past 3 months;
•7. The informed consent is signed by the patient himself or his immediate family member.
•Note: Only those who meet each of the above 7 criteria can be included in the study.

•1. Suffering from other pain conditions;
•2. Suffering from mental disorders (such as primary anxiety, primary depression, schizophrenia, etc.);
•3. Suffering from cognitive and consciousness disorder who cannot comply with the experiment procedure;
•4. Suffering from cancer, circulation, phumalnory, urinary, hematopoietic and other systems serious primary diseases;
•5. Being pregnant or lactating;
•6. Patients who have a history of alcohol or drug abuse or drug addiction;
•7. Having acupuncture contradictions.
•Note: Those who meet any of the above 7 criteria should be excluded in the study.

发起方

Chengdu University of Traditional Chinese Medicine